Aviron Message Board - Msg: 1891137

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.490

+3.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (91)	8/2/1997 1:21:00 PM
From: Pseudo Biologist	of 645

Brad, Maybe I created some confusion earlier regarding cost and pricing of doses. Let's see if I have this straight. The ESTIMATED numbers are: 1. Manufacturing cost (~cost of goods) $1-2 per dose 2. Wholesale price (how much the gross revenue per dose would be to the company) $4-5 per dose 3. "Retail" cost to patient/insurance company (includes paying the health professional) $10-12 per dose Thus, in estimating gross revenues for the vaccine company (AVIR or any other) we would multiply the $4-5 figure by the number of doses given out per year -- assuming no significant savings arising from the nasal vs. injected delivery. More later, Max

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next